neonatal sepsis: an update
Authors
abstract
sepsis is the most common cause of neonatal mortality. as per national neonatal-perinatal database (nnpd), 2002-2003, the incidence of neonatal sepsis in india was 30 per 1000 live births. signs and symptoms of sepsis are nonspecific; therefore empirical antimicrobial therapy is promptly initiated after obtaining appropriate cultures. the early manifestations of neonatal sepsis are vague and ill-defined. novel approaches in the diagnosis of neonatal sepsis include heart rate analysis on ecg, and colorimetric analysis of skin color. although blood culture is the gold standard for the diagnosis of sepsis, culture reports are available only after 48-72 hours. in this era of multidrug resistance, it is mandatory to avoid unnecessary use of antibiotics to treat non-infected infants. thus, rapid diagnostic test(s) that include interleukien-6 (il-6), neutrophil cd64 index, procalcitonin and nucleated rbc count– and differentiate the infected infants from the non-infected, particularly in the early neonatal period– have the potential to make a significant impact on neonatal care. the aim of this review is to specify the diagnostic criteria, treatment guidelines, and a summary of recent diagnostic tests of sepsis, along with the preventive measures.
similar resources
Neonatal Sepsis: An Update
Sepsis is the most common cause of neonatal mortality. As per National Neonatal-Perinatal Database (NNPD), 2002-2003, the incidence of neonatal sepsis in India was 30 per 1000 live births. Signs and symptoms of sepsis are nonspecific; therefore empirical antimicrobial therapy is promptly initiated after obtaining appropriate cultures. The early manifestations of neonatal sepsis are vague and il...
full textNeonatal Sepsis: An Update
Sepsis is the most common cause of neonatal mortality. As per National Neonatal-Perinatal Database (NNPD), 2002-2003, the incidence of neonatal sepsis in India was 30 per 1000 live births. Signs and symptoms of sepsis are nonspecific; therefore empirical antimicrobial therapy is promptly initiated after obtaining appropriate cultures. The early manifestations of neonatal sepsis are vague and il...
full textBiomarkers in early-Onset Neonatal Sepsis: An Update
Globally, an estimated 500,000 newborns die each year from serious neonatal infections, which account for about 15% of all neonatal deaths. “Suspected sepsis” is one of the most common reasons for admission to the neonatal intensive care unit (NICU). The challenge to the physician has always been trying to differentiate newborns with early onset sepsis from other non-infectious pathology whose ...
full textSepsis: an update.
This paper aims to provide an update on the main aspects of sepsis, a very relevant health care issue. A number of hypotheses have been proposed to explain its origin, involving interactions between microorganisms and the innate immune system, inflammation/immune mediation and the coagulation system. The clinical features of sepsis are variable and depend on the primary site of infection. The i...
full textNeonatal Seizure: An Update
Neonatal seizures continue to be a diagnostic and therapeutic challenge to the clinicians. Seizures can permanently disrupt neuronal development, induce synaptic reorganisation, reduce neurogenesis, alter plasticity and prime the brain to increased seizures later in life1. The prevalence of seizures is 2-3 /1000 live births in term and 10-15 /1000 in preterm deliveries2. Diagnostic and therapeu...
full textNeonatal resuscitation: an update.
Appropriate resuscitation must be available for each of the more than 4 million infants born annually in the United States. Ninety percent of infants transition safely, and it is up to the physician to assess risk factors, identify the nearly 10 percent of infants who need resuscitation, and respond appropriately. A team or persons trained in neonatal resuscitation should be promptly available ...
full textMy Resources
Save resource for easier access later
Journal title:
iranian journal of neonatologyجلد ۴، شماره ۴، صفحات ۳۹-۵۱
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023